Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: A 12-month, prospective, open-label study

Yuejin Chen, William V. Bobo, Kara Watts, Karuna Jayathilake, Tinlai Tang, Herbert Y. Meltzer

Research output: Contribution to journalArticle

20 Scopus citations

Fingerprint Dive into the research topics of 'Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: A 12-month, prospective, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences